We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.21B
AUM Growth
-$114M
Cap. Flow
-$72.1M
Cap. Flow %
-2.24%
Top 10 Hldgs %
22.3%
Holding
340
New
10
Increased
93
Reduced
152
Closed
8

Top Buys

Rank Stock Value
1
NVIV
InVivo Therapeutics Holdings Corp
NVIV
+$10.8M
2
NOV icon
NOV
NOV
+$4.27M
3
MIDD icon
Middleby
MIDD
+$3.43M
4
ROP icon
Roper Technologies
ROP
+$2.52M
5
META icon
Meta Platforms (Facebook)
META
+$2.2M

Top Sells

Rank Stock Value
1
LTM
LIFE TIME FITNESS INC
LTM
+$20.7M
2
OTEX icon
Open Text
OTEX
+$8.51M
3
TDC icon
Teradata
TDC
+$8.44M
4
TRMB icon
Trimble
TRMB
+$8.4M
5
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$7.81M

Sector Composition

Rank Sector Weight
1 Healthcare 20.32%
2 Technology 14.05%
3 Industrials 12.52%
4 Financials 10.9%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PX
26
DELISTED
Praxair Inc
PX
$36.6M 1.14%
305,889
-3,634
-1% -$443K
PAYX icon
27
Paychex
PAYX
$41.4B
$36.4M 1.13%
775,815
-6,445
-0.8% -$315K
PFE icon
28
Pfizer
PFE
$142B
$35.9M 1.12%
1,127,382
-22,515
-2% -$734K
QCOM icon
29
Qualcomm
QCOM
$160B
$35.6M 1.11%
569,177
-13,028
-2% -$889K
ABBV icon
30
AbbVie
ABBV
$455B
$35.6M 1.11%
529,801
-10,845
-2% -$708K
GILD icon
31
Gilead Sciences
GILD
$163B
$35.1M 1.09%
299,996
-4,635
-2% -$506K
IBM icon
32
IBM
IBM
$209B
$35.1M 1.09%
225,620
-8,858
-4% -$1.42M
MCD icon
33
McDonald's
MCD
$191B
$35.1M 1.09%
368,698
-5,413
-1% -$524K
JPM icon
34
JPMorgan Chase
JPM
$933B
$34M 1.06%
501,073
-4,598
-0.9% -$300K
STT icon
35
State Street
STT
$50.2B
$33.5M 1.04%
435,638
-5,894
-1% -$459K
AFL icon
36
Aflac
AFL
$64.8B
$32.9M 1.02%
1,056,456
-45,026
-4% -$1.43M
ABT icon
37
Abbott
ABT
$183B
$31.1M 0.97%
632,735
-1,212
-0.2% -$58.2K
MRK icon
38
Merck
MRK
$321B
$30.7M 0.96%
565,891
-8,107
-1% -$455K
CVX icon
39
Chevron
CVX
$383B
$29.4M 0.91%
304,555
-1,670
-0.5% -$175K
FISV
40
Fiserv Inc
FISV
$28.8B
$29.2M 0.91%
704,176
+18,044
+3% +$726K
EMLP icon
41
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$28.9M 0.9%
1,139,273
+36,794
+3% +$993K
INTC icon
42
Intel
INTC
$460B
$25.8M 0.8%
847,489
-17,402
-2% -$563K
BUD icon
43
AB InBev
BUD
$166B
$25.1M 0.78%
208,331
+696
+0.3% +$85.4K
MTD icon
44
Mettler-Toledo International
MTD
$27.9B
$24.3M 0.75%
71,029
+3,075
+5% +$1.01M
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$122B
$24M 0.75%
194,111
-9,853
-5% -$1.24M
LLTC
46
DELISTED
Linear Technology Corp
LLTC
$23.4M 0.73%
527,981
+98
+0% +$4.56K
ADP icon
47
Automatic Data Processing
ADP
$105B
$22.5M 0.7%
280,779
-3,929
-1% -$335K
EXPD icon
48
Expeditors International
EXPD
$21.8B
$22.3M 0.69%
482,854
-18,981
-4% -$894K
CELG
49
DELISTED
Celgene Corp
CELG
$21.5M 0.67%
185,797
+1,131
+0.6% +$129K
MET icon
50
MetLife
MET
$62.5B
$21.2M 0.66%
425,191
-10,255
-2% -$486K
1
2
3 4 5

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q2 2015 Portfolio in Review

As of Q2 2015, Welch & Forbes held 340 positions worth $3.21B, down 3.4% from $3.33B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Welch & Forbes's Q2 2015 filing shows 10 new, 93 increased, 152 reduced and 8 closed positions. Its largest new stake was InVivo Therapeutics Holdings Corp: 41 shares worth $12.5M. The largest sale was LIFE TIME FITNESS INC, an estimated $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Welch & Forbes's largest Q2 2015 buy was InVivo Therapeutics Holdings Corp: 41 shares worth $12.5M.
  • Welch & Forbes added most to NOV in Q2 2015, an estimated $4.27M increase.
  • Welch & Forbes's biggest Q2 2015 reduction was Open Text, cutting an estimated $8.51M.
  • Welch & Forbes fully exited LIFE TIME FITNESS INC in Q2 2015, selling an estimated $20.7M.
  • Welch & Forbes's ten largest holdings make up 22% of its $3.21B portfolio in Q2 2015.
  • Welch & Forbes opened 10 new positions and closed 8 in Q2 2015.
  • Welch & Forbes's portfolio value fell 3.4% quarter-over-quarter to $3.21B.

Based on Welch & Forbes's 13F filing for Q2 2015, filed 11 Aug 2015.